116 related articles for article (PubMed ID: 17482693)
1. The search of 'novel' mtDNA mutations in hypertrophic cardiomyopathy: MITOMAPping as a risk factor.
Bandelt HJ; Yao YG; Salas A
Int J Cardiol; 2008 Jun; 126(3):439-42. PubMed ID: 17482693
[TBL] [Abstract][Full Text] [Related]
2. Novel mitochondrial DNA mutations implicated in Noonan syndrome.
Dhandapany PS; Sadayappan S; Vanniarajan A; Karthikeyan B; Nagaraj C; Gowrishankar K; Selvam GS; Singh L; Thangaraj K
Int J Cardiol; 2007 Aug; 120(2):284-5. PubMed ID: 17092585
[TBL] [Abstract][Full Text] [Related]
3. Noonan syndrome or new autosomal dominant condition with coarctation of the aorta, hypertrophic cardiomyopathy, and minor anomalies.
Lemire EG
Am J Med Genet; 2002 Dec; 113(3):286-90. PubMed ID: 12439898
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA haplogroup 'R' is associated with Noonan syndrome of south India.
Rani DS; Dhandapany PS; Nallari P; Govindaraj P; Singh L; Thangaraj K
Mitochondrion; 2010 Mar; 10(2):166-73. PubMed ID: 20006740
[TBL] [Abstract][Full Text] [Related]
5. [ Mutation of mtDNA and genetic background of hypertrophic cardiomyopathy].
Latocha MT; Kościelny M; Mazurek UM
Wiad Lek; 2002; 55(5-6):315-24. PubMed ID: 12235699
[TBL] [Abstract][Full Text] [Related]
6. Novel mitochondrial DNA mutations in a rare variety of hypertrophic cardiomyopathy.
Prasad GN; Vanniarajan A; Emmanuel C; Cherian KM; Singh L; Thangaraj K
Int J Cardiol; 2006 May; 109(3):432-3. PubMed ID: 16266762
[TBL] [Abstract][Full Text] [Related]
7. Exaggerated status of "novel" and "pathogenic" mtDNA sequence variants due to inadequate database searches.
Bandelt HJ; Salas A; Taylor RW; Yao YG
Hum Mutat; 2009 Feb; 30(2):191-6. PubMed ID: 18800376
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA variations associated with hypertrophic cardiomyopathy.
Govindaraj P; Khan NA; Rani B; Rani DS; Selvaraj P; Jyothi V; Bahl A; Narasimhan C; Rakshak D; Premkumar K; Khullar M; Thangaraj K
Mitochondrion; 2014 May; 16():65-72. PubMed ID: 24215792
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial haplogroups modify the risk of developing hypertrophic cardiomyopathy in a Danish population.
Hagen CM; Aidt FH; Hedley PL; Jensen MK; Havndrup O; Kanters JK; Moolman-Smook JC; Larsen SO; Bundgaard H; Christiansen M
PLoS One; 2013; 8(8):e71904. PubMed ID: 23940792
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
11. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
Dereure O
Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
[No Abstract] [Full Text] [Related]
12. An online locus-specific mutation database for familial hypertrophic cardiomyopathy.
Fung DC; Yu B; Littlejohn T; Trent RJ
Hum Mutat; 1999; 14(4):326-32. PubMed ID: 10502780
[TBL] [Abstract][Full Text] [Related]
13. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
Alcalai R; Seidman JG; Seidman CE
J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152
[TBL] [Abstract][Full Text] [Related]
14. Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.
Keren A; Syrris P; McKenna WJ
Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):158-68. PubMed ID: 18227814
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
16. Selected mutations in the myosin binding protein C gene in the Polish population of patients with hypertrophic cardiomyopathy.
Rudziński T; Selmaj K; Drozdz J; Krzemińska-Pakuła M
Kardiol Pol; 2008 Aug; 66(8):821-5; discussion 826-7. PubMed ID: 18803133
[TBL] [Abstract][Full Text] [Related]
17. A new phenotypic marker of hypertrophic cardiomyopathy.
Ker J
Lancet; 2014 Nov; 384(9956):1731. PubMed ID: 25455237
[No Abstract] [Full Text] [Related]
18. Mitochondrial DNA abnormalities in hypertrophic cardiomyopathy.
Odawara M; Yamashita K
Lancet; 1999 Jan; 353(9147):150. PubMed ID: 10023924
[No Abstract] [Full Text] [Related]
19. More introgression with less gene flow: chloroplast vs. mitochondrial DNA in the Picea asperata complex in China, and comparison with other Conifers.
Du FK; Petit RJ; Liu JQ
Mol Ecol; 2009 Apr; 18(7):1396-407. PubMed ID: 19284474
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA and gastrointestinal motor and sensory functions in health and functional gastrointestinal disorders.
Camilleri M; Carlson P; Zinsmeister AR; McKinzie S; Busciglio I; Burton D; Zaki EA; Boles RG
Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G510-6. PubMed ID: 19147801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
